Cytomedix Inc (NASDAQOTH:CMXI)

CAPS Rating: 3 out of 5

A biotechnology company that develops and licenses autologous cellular therapies, including Cytomedix's proprietary AutoloGel(tm) Process to produce a platelet rich plasma gel for the treatment of wounds.

Recs

0
Player Avatar Kvedarna (99.48) Submitted: 2/21/2013 7:42:06 PM : Outperform Start Price: $0.53 CMXI Score: -48.89

Zzzzzzzzzman

Featured Broker Partners


Advertisement